Show simple item record

Bile salt transport after selective damage to acinar zone 3 hepatocytes by bromobenzene in the rat

dc.contributor.authorGumucio, Jorge J.en_US
dc.contributor.authorKatz, Michael E.en_US
dc.contributor.authorMiller, Deborah L.en_US
dc.contributor.authorBalabaud, Charles P.en_US
dc.contributor.authorGreenfield, Jeremy M.en_US
dc.contributor.authorWagner, Renate M.en_US
dc.date.accessioned2006-04-07T17:33:08Z
dc.date.available2006-04-07T17:33:08Z
dc.date.issued1979-08en_US
dc.identifier.citationGumucio, Jorge J., Katz, Michael E., Miller, Deborah L., Balabaud, Charles P., Greenfield, Jeremy M., Wagner, Renate M. (1979/08)."Bile salt transport after selective damage to acinar zone 3 hepatocytes by bromobenzene in the rat." Toxicology and Applied Pharmacology 50(1): 77-85. <http://hdl.handle.net/2027.42/23510>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WXH-4DDNKBM-15/2/1e140ebd6d3402d2a9ed2bc6b041c9ecen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/23510
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=494301&dopt=citationen_US
dc.description.abstractTo quantitate the contribution of acinar zone 3 hepatocytes (centrilobular cells) to the transport of physiological concentrations of taurocholate, selective acinar zone 3 cell damage was induced in female rats by the administration of bromobenzene. Forty-eight hours later, livers were perfused in situ. Oxygen consumption, gluconeogenesis, transport of [14C]taurocholate into bile, bile flow and capacity for removal of indocyanine green were assessed. The removal of single doses of [14C]taurocholate injected into the portal vein at loads of 0.025 and 0.11 [mu]mol/kg was then measured. Bromobenzene-treated livers removed 80-85% of the injected dose while control livers removed about 98%. The percentage of the injected dose removed by each group at each load of taurocholate remained fairly constant. In separate experiments, [14C]taurocholate was administered in successive single injections at loads between 0.20 and 75 [mu]mol/kg. The percentage of the injected dose removed remained constant and was similar to that observed at lower loads of taurocholate until a dose of 1.0 [mu]mol/kg was used. At higher loads, the percentage of the injected dose removed decreased progressively, suggesting that the uptake process was reaching saturation. These results showed that acinar zone 3 hepatocytes contributed to the removal of 13-18% of a physiological load of taurocholate. Furthermore, a 50% decrease in bile flow was observed after bromobenzene administration. This suggested that damage to the centrilobular area is followed by alterations in bile flow and by the passage of at least 13-18% of the bile salts reaching the acinus into the general circulation. In addition, taurocholate removal after carbon tetrachloride-induced damage to the centrilobular area was studied. Twelve to eighteen percent of the injected dose of [14C]taurocholate was found in the hepatic vein effluent, values similar to the results obtained after bromobenzene-induced damage.en_US
dc.format.extent782169 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleBile salt transport after selective damage to acinar zone 3 hepatocytes by bromobenzene in the raten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, Section of Gastroenterology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationumDepartment of Internal Medicine, Section of Gastroenterology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationumDepartment of Internal Medicine, Section of Gastroenterology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationumDepartment of Internal Medicine, Section of Gastroenterology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationumDepartment of Internal Medicine, Section of Gastroenterology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationumDepartment of Internal Medicine, Section of Gastroenterology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.identifier.pmid494301en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/23510/1/0000465.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0041-008X(79)90494-0en_US
dc.identifier.sourceToxicology and Applied Pharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.